ArticleFrontiers in oncology2023

Pan-cancer analysis reveals that G6PD is a prognostic biomarker and therapeutic target for a variety of cancers.

Tao Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.